Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyalgan for Knee Osteoarthritis
NCT00323778Phase 3Terminated
- Sponsor
- Hospital for Special Surgery
- Start
- May 2006
- Primary completion
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of sodium hyaluronate in knee osteoarthritis (OA) (2 arms), sponsored by Hospital for Special Surgery. Primary endpoints: Knee cartilage response assessed by MRI at 1 year and Knee cartilage response assessed by X-ray at 1 year. Started May 2006; status: terminated.
02
Drugs
sodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00323778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323778.